Table 3

Stratification analysis of risk of major adverse cardiovascular events among different group in the model 1 matched population

	Any HZ vaccine		No HZ vaccine
	n	No. of event	n	No. of event	HR (95% CI)
Age
50–65	28 258	1634	28 258	1968	0.80 (0.75 to 0.86)
>65	16 903	1859	16 903	1723	0.83 (0.78 to 0.89)
Sex
Female	22 591	1559	22 591	1808	0.77 (0.72 to 0.83)
Male	20 603	1665	20 603	1995	0.74 (0.69 to 0.79)
Type 1 diabetes	230	10	230	16	0.25 (0.08 to 0.75)
Type 2 diabetes	42 503	2945	42 503	3588	0.71 (0.68 to 0.75)

If the patient’s count is 1–10, the results indicate a count of 10.
Model 1 indicates any HZ vaccination versus no HZ vaccination population.
Any vaccine, Shingrix or Zostavax; HZ, herpes zoster.